Assessment of the clinical meaningfulness of change in dermatology life quality index scores [Abstract]

Salek, Mir-saeed, Sturkey, R., Basra, M. and Finlay, Andrew Yule ORCID: https://orcid.org/0000-0003-2143-1646 2010. Assessment of the clinical meaningfulness of change in dermatology life quality index scores [Abstract]. Pharmacy World and Science 32 (2) , p. 236. 10.1007/s11096-010-9378-9

Full text not available from this repository.

Abstract

HRQoL instruments such as the DLQI are useful in assessing how different skin conditions affect patients’ lives, efficacy of patients’ treatment over time and as an additional measure of benefit-risk ratio for certain drugs. If however any decisions are to be made on the basis of a change in HRQoL score over time, then there needs to be a definition of what change in score is meaningful to the patient. The smallest change in score over time that would be meaningful to the patient is called the Minimal Important Difference, or MID. The aim was to determine the MID for the DLQI.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Pharmacy
Subjects:	R Medicine > RL Dermatology
Additional Information:	ESCP–GSASA 38th symposium on clinical pharmacy 30 years of clinical pharmacy; a bright future ahead, 3rd–6th November 2009, Geneva, Switzerland
Publisher:	Springer Verlag
ISSN:	0928-1231
Last Modified:	14 Dec 2022 03:01
URI:	https://orca.cardiff.ac.uk/id/eprint/32851

Actions (repository staff only)

Edit Item